Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone in insomnia related to rheumatoid arthritis
NCT00367965Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Feb 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started Feb 2004; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00367965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367965.